Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Imfinzi
Imfinzi
ESMO: AstraZeneca wows with Imfinzi's 11-month survival edge in lung cancer
Fierce Pharma
Sun, 09/10/17 - 11:43 am
ESMO
AstraZeneca
Imfinzi
lung cancer
AstraZeneca fights back in cancer with new hires, fast drug status
Yahoo/Reuters
Mon, 07/31/17 - 09:56 am
AstraZeneca
Imfinzi
immuno-oncology
AstraZeneca, Merck team up on Lynparza combos in collaboration worth up to $8.5B
Fierce Pharma
Fri, 07/28/17 - 11:31 am
AstraZeneca
Merck
Lynparza
Imfinzi
AstraZeneca lung cancer immunotherapy trial failure sends shares plunging
Stat
Thu, 07/27/17 - 09:59 am
AstraZeneca
Mystic
immuno-oncology
clinical trials
tremelimumab
Imfinzi
Investors — and AstraZeneca CEO Pascal Soriot — are getting a tad nervous as MYSTIC data loom
Endpoints
Thu, 06/29/17 - 09:23 am
investors
AstraZeneca
Pascal Soriot
Imfinzi
tremelimumab
immuno-oncology
clinical trials
AstraZeneca Shows That With Immune Cancer Drugs, No One Knows What's Next
Forbes
Fri, 05/12/17 - 11:44 am
AstraZeneca
oncology
Imfinzi
Opdivo
Keytruda
AstraZeneca’s shares spike on positive PhIII lung cancer data — but it’s not MYSTIC
Endpoints
Fri, 05/12/17 - 09:40 am
AstraZeneca
clinical trials
durvalumab
Imfinzi
non-small cell lung cancer
Move over, AstraZeneca. Pfizer and Merck KGaA are the newest bladder cancer drugmakers in town
Fierce Pharma
Wed, 05/10/17 - 09:31 am
Pfizer
Merck KGaA
AstraZeneca
Bavencio
avelumab
bladder cancer
Imfinzi
FDA
Opdivo
Tecentriq
AstraZeneca's New Drug: Too Little, Too Late?
Seeking Alpha
Mon, 05/8/17 - 09:51 pm
AstraZeneca
Imfinzi
bladder cancer
Pages
« first
‹ previous
1
2
3
4